SubsidieMeestersThe first non-surgical repair for Pelvic Organ Prolapse
Escala Medical's Apyx aims to provide a minimally invasive solution for early-stage pelvic organ prolapse, enhancing quality of life and preventing condition progression through clinical trials and commercialization.
Projectdetails
Introduction
Pelvic Organ Prolapse (POP) affects nearly 50% of women over 40 years old globally. 89% of the cases seek treatment for symptomatic early-stage prolapse.
Current Challenges
Despite the high prevalence and the progression of POP over time, patients currently cannot be offered a repair solution until the condition worsens enough for surgical intervention.
Surgical Interventions
However, the surgical interventions for prolapse have several side effects, including:
- Prolonged recovery
- Pelvic pain
- Relapses of POP
Innovative Solution
Escala Medical has developed a minimally invasive and incision-free repair intervention for early-stage POP repair - Apyx.
Apyx Overview
Apyx is the first medical device for treating early-stage prolapse, regaining quality of life and preventing prolapse deterioration for the vast majority of currently unaddressed POP sufferers.
Project Goals
The EIC project will:
- Finalize the development of Apyx
- Conduct clinical trials
- Support scale-up and commercialization activities
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.500.000 |
| Totale projectbegroting | € 5.067.216 |
Tijdlijn
| Startdatum | 1-10-2023 |
| Einddatum | 30-9-2025 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- ESCALA MEDICAL LTDpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
A new cardioprotective drug for acute treatment of myocardial infarctionResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Clear, scalable and scientific framework to measure terrestrial biodiversity3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value. | EIC Accelerator | € 2.252.714 | 2024 | Details |
Novel and Scalable microbial products for REgenerative agricultureN-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data SecurityQuside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors. | EIC Accelerator | € 2.499.999 | 2024 | Details |
A new cardioprotective drug for acute treatment of myocardial infarction
ResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies.
Clear, scalable and scientific framework to measure terrestrial biodiversity
3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value.
Novel and Scalable microbial products for REgenerative agriculture
N-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency.
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data Security
Quside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
reGeneRative bone Implant for the treatment of hip dysPlasiaGRIP aims to revolutionize hip dysplasia treatment with personalized, 3D-printed regenerative bone implants, enhancing integration and reducing invasiveness compared to current methods. | ERC POC | € 150.000 | 2022 | Details |
A completely biological and human tissue-engineered mesh produced from Cell-Assembled extracellular Matrix (CAM) in vitro for the treatment of Pelvic Organ Prolapse (POP)This project aims to develop a biological, tissue-engineered mesh using Cell-Assembled extracellular Matrix to treat Pelvic Organ Prolapse, demonstrating its safety and effectiveness in preclinical models. | ERC POC | € 150.000 | 2023 | Details |
PELVIc Floor Evaluation live TRACKing – Real-time prediction of perineal traumaPELVITRACK aims to prevent pelvic floor disorders by developing a real-time monitoring solution for perineal tearing during vaginal deliveries through interdisciplinary research and innovative technologies. | EIC Pathfinder | € 3.209.102 | 2025 | Details |
A completely biological and human tissue-engineered sling produced from Cell-Assembled extracellular Matrix (CAM) in vitro for the treatment of Stress Urinary Incontinence (SUI)This project aims to develop and validate soft, biologically-based CAM slings for treating Stress Urinary Incontinence, addressing complications of synthetic slings through in vivo testing in sheep. | ERC POC | € 150.000 | 2025 | Details |
reGeneRative bone Implant for the treatment of hip dysPlasia
GRIP aims to revolutionize hip dysplasia treatment with personalized, 3D-printed regenerative bone implants, enhancing integration and reducing invasiveness compared to current methods.
A completely biological and human tissue-engineered mesh produced from Cell-Assembled extracellular Matrix (CAM) in vitro for the treatment of Pelvic Organ Prolapse (POP)
This project aims to develop a biological, tissue-engineered mesh using Cell-Assembled extracellular Matrix to treat Pelvic Organ Prolapse, demonstrating its safety and effectiveness in preclinical models.
PELVIc Floor Evaluation live TRACKing – Real-time prediction of perineal trauma
PELVITRACK aims to prevent pelvic floor disorders by developing a real-time monitoring solution for perineal tearing during vaginal deliveries through interdisciplinary research and innovative technologies.
A completely biological and human tissue-engineered sling produced from Cell-Assembled extracellular Matrix (CAM) in vitro for the treatment of Stress Urinary Incontinence (SUI)
This project aims to develop and validate soft, biologically-based CAM slings for treating Stress Urinary Incontinence, addressing complications of synthetic slings through in vivo testing in sheep.